Skip to main content
Atrás
Watch Compare

Fulcrum Therapeutics, Inc.

Calidad de datos: 83%
FULC
Nasdaq Manufacturing Chemicals
$7.91
▲ $0.01 (0.13%)
Cap. Mercado: 526.81 M
Precio
$7.91
Cap. Mercado
526.81 M
Rango del Día
$7.82 — $8.03
Rango de 52 Semanas
$2.49 — $15.74
Volumen
377,940
Apertura $7.83
Promedio 50D / 200D
$8.90
11.08% below
Promedio 50D / 200D
$8.80
10.10% below

Quick Summary

Puntos Clave

Negative free cash flow of -60.38 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-36.28%
Above sector avg (-51.02%)
ROIC-31.66%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio17.70
Interest CoverageN/A

Valoración

PE (TTM)
-7.04
Below sector avg (-1.98)
P/B Ratio2.66
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -7.0 -2.0
P/B 2.7 5.1
ROE % -36.3 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

PINK logo PINK Simplify Health Care ETF
0.39% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.08% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.05% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -74.88 M
ROE -36.28% ROA -33.75%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -60.38 M
ROIC -31.66% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 17.70
Interest Coverage N/A Asset Turnover N/A
Working Capital 194.23 M Tangible Book Value 198.37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7.04 Forward P/E N/A
P/B Ratio 2.66 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -11.46%
Market Cap 526.81 M Enterprise Value 479.73 M
Per Share
EPS (Diluted TTM) -1.18 Revenue / Share N/A
FCF / Share -0.91 OCF / Share -0.90
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80.63%
SBC-Adj. FCF -73.70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -74.88 M -9.73 M -97.34 M -109.87 M -80.85 M
EPS (Diluted) -1.18 -0.16 -1.59 -2.44 -2.29
Gross Profit — — — — —
Operating Income -84.77 M -21.90 M -110.66 M -112.56 M -81.05 M
EBITDA — — — — —
R&D Expenses 56.10 M 63.39 M 71.80 M 76.78 M 69.70 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 366.28 M 260.72 M 257.69 M 226.69 M 235.00 M
Total Liabilities 17.28 M 17.68 M 22.50 M 27.74 M 23.46 M
Shareholders' Equity 349.00 M 243.03 M 235.19 M 198.94 M 211.54 M
Total Debt — — — — —
Cash & Equivalents 197.53 M 58.21 M 25.56 M 35.10 M 35.41 M
Current Assets 357.48 M 249.92 M 242.20 M 207.52 M 226.00 M
Current Liabilities 13.05 M 11.04 M 13.68 M 16.73 M 19.20 M